WALTHAM, Mass. (AP) _ AMAG Pharmaceuticals Inc. (AMAG) on Tuesday reported a fourth-quarter loss of $10.6 million, after reporting a profit in the same period a year earlier.
On a per-share basis, the Waltham, Massachusetts-based company said it had a loss of 31 cents. Earnings, adjusted for non-recurring costs, were $1.52 per share.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.72 per share.
The specialty drugmaker posted revenue of $151.6 million in the period, which also fell short of Street forecasts. Four analysts surveyed by Zacks expected $152.3 million.
For the year, the company reported a loss of $2.5 million, or 7 cents per share, swinging to a loss in the period. Revenue was reported as $532.1 million.
AMAG Pharmaceuticals shares have declined 35 percent since the beginning of the year. The stock has climbed nearly 6 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMAG at https://www.zacks.com/ap/AMAG
Keywords: AMAG Pharmaceuticals, Earnings Report